Tuesday, July 30, 2024

Here's a short summary of drug sales for 4 pharmaceutical companies from earnings reports in Q2 '24. Two of the firms reported this morning (July 30th) so the data is fresh.  

Included in this small sample are Johnson & Johnson (ticker: JNJ), Pfizer (ticker: PFE), Abbvie (ticker: ABBV) and Merck (ticker: MRK).


Using our Excel Add in and our Disclosures query tools, we are able to extract these segments in a flash.  

A few noteworthy things.  Drugs that formed a significant portion of revenue in Q2 2024 are 

  • Merck Keytruda (45%) and Gardasil (15%)  
  • J&J  Stelara (13%) and Darzalex (13%) 
  • AbbVie Humira (16%) Skyrizi (16%)
  • Pfizer Elliquis (14%)

Time Series of Revenues by Firm / Drug below








FREE Calcbench Premium
Two Week Trial

Research financial & accounting data like never before. Get features designed for better insights. Try our enhanced Excel Add-in. Sign up now to try the Premium Suite.